Dose-dependent effects of a genistein-enriched diet in the heart of ovariectomized mice by Ba Tiep Nguyen et al.
RESEARCH PAPER
Dose-dependent effects of a genistein-enriched diet
in the heart of ovariectomized mice
Ba Tiep Nguyen • Georgios Kararigas •
Hubertus Jarry
Received: 28 July 2012 / Accepted: 16 October 2012 / Published online: 30 October 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract The isoflavone genistein is used as a pharma-
cological compound and as a food supplement. The dura-
tion and the level of exposure of humans to genistein are
considerable. However, the magnitude of genistein-sup-
plemented dietary interventions necessary to induce any
changes in the heart has not been studied so far. The aim of
this study was to investigate the dose-dependent effects of
dietary genistein in the disease- and stress-free mouse
heart. Female C57BL/6J mice at the age of 2 months were
ovariectomized and randomly assigned to feed on diets
with seven different genistein doses (0.01, 0.03, 0.1, 0.3, 1,
3 and 10 g genistein/kg food) for 3 months. Mice with
intact ovaries or ovariectomized fed on soy-free diets were
used as controls. Ovariectomy led to an increase in body
weight, while the two highest genistein doses prevented
this increase. Absolute uterus weight was decreased in the
ovariectomized group and all genistein groups except for
the 10 g/kg food group compared with the intact ovaries/
soy-free group. Considering cardiac mass, although the 3
and 10 g/kg food groups had significantly lower absolute
heart weight than all other groups, heart-to-body-weight
ratios did not differ between these two groups and the
intact ovaries/soy-free group, while all remaining groups
had smaller ratios. Next, we observed dose-dependent
effects of genistein on cardiac gene expression. The present
findings indicate that exposure of female mice to the soy
isoflavone genistein influences body weight and cardiac
mass and gene expression in a dose-dependent manner.
Human exposure to dietary genistein supplements may
influence cardiac function.






Cardiovascular disease (CVD) represents a major cause of
morbidity and mortality in the developed world (Lakatta 2002;
Yusuf et al. 2001). In women, the incidence of CVD rises
substantially with menopause. Due to this, it has been generally
believed that the loss of oestrogen at menopause might be a
major contributing factor to the increased risk for CVD.
Consequently, several combinations of hormone therapies
with naturally occurring and/or synthetic products have been
used widely. However, unexpected negative findings from
large randomized clinical trials (Anderson et al. 2004; Rossouw
et al. 2002) and conflicting results from animal studies have led
to controversy about the use of hormone therapies.
Along this line, soy-rich foods have been studied
extensively for their ability to reduce cholesterol levels
(Zhan and Ho 2005). Epidemiological studies suggest that
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the coronary benefits of soy extend beyond lipid lowering
(Zhang et al. 2003). Soy is a rich source of isoflavones and
phytoestrogens (Murphy et al. 2002). Genistein (GEN) is
an isoflavone derivative found in plants, which has been
shown to inhibit tyrosine kinases (Akiyama et al. 1987) and
could, therefore, lead to detrimental effects in the heart
(Sereno et al. 2008; Force et al. 2007) and to interact with
oestrogen receptors (Davis et al. 1999). The latter activity
of GEN has led to its use as a substitute of oestrogen in
hormone therapy regimes. However, GEN is not only used
as a pharmacological compound but also as a food sup-
plement. Therefore, the duration and the level of exposure
of humans to GEN are considerable.
The effects of GEN have been generally studied in the
classical target organs of oestrogen, such as mammary
gland, uterus and bone. However, little is known about the
potential role of dietary GEN directly in the disease- and
stress-free heart. In the present study, we investigated the
dose-dependent effects of dietary GEN in the hearts of
female C57BL/6J mice. We tested the hypothesis that GEN
will affect body weight, cardiac mass and gene expression
in a dose-dependent manner.
Materials and methods
Animals and diets
Female C57BL/6J mice (Winkelmann, Borchen) at 2 months
of age were ovariectomized (OVX) and randomized into
seven groups receiving a genistein-enriched diet (Ssniff,
Soest) at a concentration of 0.01, 0.03, 0.1, 0.3, 1, 3 and 10 g/kg
food, respectively. An OVX group and another with intact
ovaries both receiving a soy-free diet were used as controls.
The experimental design is shown in Fig. 1. All mice were
fed with regular rodent diet containing soy after weaning.
Immediately after OVX, mice were fed with a soy-free diet,
enriched with or without GEN. The mice were kept on a
12:12-h light/dark cycle in temperature-controlled rooms
with water ad libitum. All mice were monitored throughout
the study, and no mouse showed signs of intoxication or
health impairment. After 3 months, the mice were killed
under CO2 anaesthesia. Following body and organ weight
measurements, organs were snap frozen in liquid nitrogen
and stored at -80 C until RNA isolation. All experiments
were approved by the Landesamt fu¨r Verbraucherschutz,
Braunschweig, Germany.
Quantitative real-time RT-PCR
Total RNA was isolated from left ventricles using the
RNeasy Total RNA Kit (Qiagen, Hilden). cDNA was syn-
thesized using the M-MLV Reverse Transcriptase (Promega,
Madison) and random primers (Invitrogen, Karlsruhe).
Reactions were performed as described previously (Karari-
gas et al. 2011; Nguyen et al. 2012) using SYBR Green
(Applied Biosystems, Foster City). For Myocd analysis, we
used the Mm_Myocd_1_SG primers, for Esr1 the
Mm_Esr1_2_SG primers and for Esr2 the Mm_Esr2_1_SG
primers; all from the QuantiTect Primer Assay (Qiagen,
Hilden). For Igf1 analysis, we used the following: forward
primer 50-CTTCAACAAGCCCACAGGCTA-30, reverse
primer 50-GCTCCGGAAGCAACACTCAT-30 and probe
50-CTCCAGCATTCGGAGGGCACCTC-30.
Statistical analysis
All data were analysed statistically using the R version 2.14.2
software. Data are shown as the mean ± SEM. Comparisons
between multiple groups were performed using analysis of
variance with Tukey’s post hoc test adjusting for multiple
comparisons, considering P B 0.05 significant.
Results
Study design
In the present study, we investigated the dose-dependent
effects of GEN in the hearts of OVX mice under
Fig. 1 Study design. Female
C57BL/6J mice were
ovariectomized and fed diets
with seven different GEN doses
for 3 months. Mice with intact
ovaries or ovariectomized fed
on soy-free diets were used as
controls
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physiological conditions. We tested the hypothesis that
GEN will affect body weight, cardiac mass and gene
expression in a dose-dependent manner. For this purpose,
we selected seven concentrations of GEN to include a wide
range of GEN levels with relevance to human consumption
and doses of GEN that have been previously shown to exert
oestrogenic-like effects in rodents (Nguyen et al. 2012).
Mice that received GEN were ovariectomized and a further
OVX group on soy-free diet was used as one of two con-
trols. The second control group was soy-free-fed mice with
intact ovaries (Fig. 1).
Food consumption and actual GEN intake
We verified the extent of food consumption in all groups
and asked whether an enriched diet with different amounts
of GEN would affect the intake of food. Based on own
previous experience and the literature, we had expected an
average intake of 3 g food per mouse per day. We found
that the amount of food consumption in the groups of 3 and
10 g GEN/kg food was significantly decreased compared
with the food consumption of all remaining groups, where
no significant effect on average food consumption was
observed (Table 1). Considering the average food con-
sumption, we were able to calculate the actual GEN intake
per mouse in each group (Table 1).
Dose-dependent effects of dietary GEN on body weight
As it was expected, the removal of the ovaries led to an
increase in body weight when compared to mice with their
ovaries intact (24 % increase; P \ 0.001) (Fig. 2).
However, the two highest concentrations of GEN, that is, 3
and 10 g/kg food, were able to inhibit body weight gain
(Fig. 2). In fact, the group of mice fed on the diet with the
highest GEN content had a significantly lower body weight
than the group of mice with intact ovaries (29 % lower;
P \ 0.001) (Fig. 2). On the other hand, the remaining doses
of GEN did not have any major effect on body weight
(Fig. 2).
Dose-dependent effects of oral GEN treatment
on uterus and heart weight
Next, we assessed the weight of the uterus of mice in the
different groups. As expected, we found that OVX mice
had a significant decrease in uterus weight compared with
mice with intact ovaries (7.5-fold decrease; P \ 0.001)
(Fig. 3a). In contrast, the GEN 10 g/kg food group had
significantly higher uterus weight than the intact ovaries/
soy-free-fed group (21 % higher; P \ 0.05) (Fig. 3a). On
the other hand, although the dose of 3 g GEN/kg food led
to a significant increase in uterus weight compared with all
remaining GEN groups, the uterus weight of this group was
significantly lower than that of mice with intact ovaries
(1.54-fold; P \ 0.001) (Fig. 3a). All these differences were
still significant even after relating uterus weight to body
weight (Fig. 3b). The concentration of GEN 1 g/kg food or
lower did not exert major effects on uterus weight.
On the other hand, the effects of GEN on heart weight
were more complex. In particular, the absolute heart weight
of mice fed on the two highest GEN concentrations, that is,
3 and 10 g/kg food, was significantly lower when com-
pared with all remaining groups (Fig. 4a). However, when
Table 1 Food consumption and actual GEN intake
Intact SF OVX SF GEN 0.01 GEN 0.03 GEN 0.1 GEN 0.3 GEN 1 GEN 3 GEN 10
Food consumption (g/mouse/day) 3.39 3.27 3.19 3.27 3.35 3.33 3.18 2.86a 2.82a
Actual GEN intake (mg/mouse/day) – – 0.032 0.098 0.36 0.99 3.18 8.58 28.2
a P \ 0.05 versus all groups
Fig. 2 Dose-dependent effects
of GEN on body weight.
Ovariectomy led to an increase
in body weight, while the two
highest GEN doses prevented
this increase. Increased body
weight was observed in all
remaining GEN groups
compared with the intact SF
group. a P \ 0.001 and b non-
significant versus intact SF
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considering the heart weight related to body weight, we
discovered that there was no significant difference between
the intact ovaries/soy-free-fed control group and the 3 and
10 g GEN/kg food groups (Fig. 4b). On the other hand,
OVX and all other GEN-fed mice had significantly lower
heart-to-body-weight ratios (Fig. 4b).
Fig. 3 Dose-dependent effects
of GEN on uterus weight.
a Absolute uterus weight was
decreased in the OVX group
and all GEN groups except for
GEN 10 compared with the
intact SF group. b Uterus-to-
body-weight ratio showed the
same pattern. a P \ 0.001 and
c 0.05 versus intact SF;
b P \ 0.001 versus OVX SF
Fig. 4 Dose-dependent effects
of GEN on heart weight.
a Although GEN 3 and 10 had
significantly lower heart weight
than all other groups, b heart-to-
body-weight ratios did not differ
between these two groups and the
intact SF group, while all
remaining groups had smaller
ratios. a P \ 0.01, b 0.001 and
c non-significant versus intact SF
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Dose-dependent effects of dietary GEN on gene
expression in the heart
Following the observed effects of GEN on body and organ
weight, we assessed the role of GEN on cardiac gene
expression. In particular, we studied the expression of
insulin-like growth factor 1 (Igf1) and myocardin (Myocd)
in the mouse left ventricle with real-time RT-PCR. We
chose Igf1, because it is involved in Akt signalling pro-
tecting cardiomyocytes against injury (Fujio et al. 2000),
and Myocd as it has been previously shown to be under
nuclear hormone receptor regulation (Li et al. 2007). We
found that the GEN 1, 3 and 10 g/kg food groups of mice
had the highest expression of Igf1 (Fig. 5a). Although in the
remaining GEN groups, there was a lowering trend in the
expression of Igf1, no statistical significance was reached.
On the other hand, the expression levels of Myocd were
significantly lower in the OVX and the GEN 0.01–0.3 g/kg
food groups than the intact ovaries/soy-free-fed control
group (Fig. 5b). In contrast, the expression of Myocd in the
1–10 g GEN/kg food was not statistically different from
that in the intact ovaries/soy-free-fed group (Fig. 5b). Fol-
lowing these differences, we verified the expression levels
of both oestrogen receptor subtypes. We found that their
expression was similar in all groups (Fig. 6).
Discussion
In the present study, we investigated the dose-dependent
effects of GEN in the heart of disease- and stress-free mice.
We employed seven different concentrations of GEN in
OVX mice and found that significant effects were exerted
on body and organ weight and cardiac gene expression by
the three highest GEN concentrations.
In particular, we discovered that although the average
daily food intake per mouse was comparable in most
groups, mice fed on a diet with the two highest GEN doses
exhibited a significant decrease in food intake. While this
was a surprising finding and there is no obvious explana-
tion for this difference, we anticipate that GEN might exert
direct effects on the brain, which in turn has a major role in
the control of food intake (Del Parigi et al. 2002). Subse-
quently, we found that OVX mice had an increase in their
body weight compared with mice with intact ovaries.
However, this increase was hindered in the GEN 3 and
10 g/kg food groups, which may be the result of the
combination of lower food intake in these groups and
unrecognized molecular pathways involved in the control
of body weight and adiposity signals that may be regulated
by high GEN levels. In fact, it has been suggested that
controlling meal size may be relevant for the development
Fig. 5 Dose-dependent effects
of GEN on cardiac gene
expression. GEN influenced the
expression of a Igf1 and
b Myocd in a dose-dependent
manner. a P \ 0.05, b 0.01,
c 0.001 and d non-significant
versus intact SF; e P \ 0.01 and
f 0.001 versus OVX SF
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of efficacious therapeutic tools to reduce eating (Lutz
2006). Along this line, the leptin receptor long form and the
SH2-tyrosine phosphatase Shp2 might be potential targets
of GEN in the brain, whose modulation by leptin and
oestrogen signalling regulates food intake and energy bal-
ance (He et al. 2012; Ring and Zeltser 2010). Based on our
findings, we propose that GEN supplementation of a well-
balanced healthy diet might be instrumental in whole body
weight loss approaches. However, deciphering the under-
lying molecular pathways holds the promise for the
development of novel therapeutic means.
Assessing absolute heart weight, we found that mice fed
on the two highest GEN doses had significantly smaller
hearts than any other GEN group. This finding associated
with the effects on body weight fits the obvious model that
a bigger body requires a bigger heart and vice versa.
However, heart-to-body-weight ratios revealed that there
were no significant differences between the groups with the
two highest GEN concentrations and the intact ovaries/soy-
free-fed control group. This suggests that in the absence of
endogenous hormones and particularly oestrogen as a result
of ovariectomy, GEN might be crucial for the maintenance
of cardiac stability. Preserving the size and structure of an
organ would be of utmost importance for the organ’s
function. Therefore, we believe that GEN supplementation
of a normal diet may be beneficial for cardiac function,
especially in postmenopausal women. However, this
hypothesis needs to be tested in a study where cardiac
function is also assessed.
On the other hand, it should be taken into account that
hormonal actions in the heart may be sex specific and not
always beneficial (Kararigas et al. 2010, 2012). In fact, in a
genetic model of hypertrophic cardiomyopathy, it was
shown that a soy-based diet was beneficial in females but
harmful in males (Luczak et al. 2011). The observed bene-
ficial effects in females were postulated to be attributed to
increased Igf1 pathway expression (Luczak et al. 2011).
Downstream activating signalling of Akt by Igf1 in cardio-
myocytes is protective against injury (Fujio et al. 2000). To
this extent, premenopausal women have been shown to have
significantly higher levels of nuclear-localized phosphory-
lated Akt in cardiomyocytes compared with age-matched
men or postmenopausal women (Camper-Kirby et al. 2001).
In the present study, we found that the three highest doses of
GEN, that is, 1, 3 and 10 g/kg food, led to increased Igf1
expression compared with both control groups. Based on
these findings, we put forward that the GEN-induced Igf1
expression is beneficial for the heart. However, considering
sexual dimorphism in hormonal effects, it would be very
interesting to verify the role of GEN in the disease- and
stress-free heart of male mice.
The potential use of GEN as a natural selective oestro-
gen receptor modulator (SERM) seems to be promising. In
long-term hormone therapy regimens, the use of oestrogen
Fig. 6 Left ventricular
expression of oestrogen
receptors. Expression levels of
Esr1 (a) and Esr2 (b) were
similar in all treatment groups
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may exert negative effects in the breast and the endome-
trium. However, a clear advantage of GEN is that it may
behave as an oestrogen receptor antagonist in both of these
tissues. Along this line, in a previous study, we did not
observe any oestrogenic-like effects of GEN in the uterus,
as assessed by the expression of the insulin-like growth
factor 1 (Igf1) gene (Nguyen et al. 2012). This indeed
supports the notion that genistein is not an oestrogen
receptor agonist in the uterus, whose inner cell layer is the
endometrium. In addition, the incidence of uterine dys-
plasia was low in ovariectomized rats fed GEN, suggesting
a weak oestrogen receptor agonist role of GEN also in the
rat uterus (Aidoo et al. 2005).
In conclusion, we have identified dose-dependent effects
of dietary GEN on body weight and directly on cardiac
mass and gene expression. Further research is required to
study GEN effects on cardiac function and to elucidate the
molecular factors mediating these effects.
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